Evidence map›Paper›PMID 30837539›Full record

ArticleScientific reports2019

Interpretation of EBV infection in pan-cancer genome considering viral life cycle: LiEB (Life cycle of Epstein-Barr virus).

Hyojin Song, Yoojoo Lim, Hogune Im, Jeong Mo Bae, Gyeong Hoon Kang, Junhak Ahn, Daehyun Baek, Tae-You Kim, Sung-Soo Yoon, Youngil Koh

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. CD4Science translational medicine · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. [Research status of Epstein Barr virus in children with adenotonsillar hypertrophy].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Hyojin SongCancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.ORCID 0000-0002-2916-0644
Yoojoo LimDepartment of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Hogune ImGenome Opinion, Ansan, Gyeonggi-do, Republic of Korea.
Jeong Mo BaeDepartment of Pathology, Seoul National University Hospital, Seoul, Republic of Korea.ORCID 0000-0003-0462-3072
Gyeong Hoon KangDepartment of Pathology, Seoul National University Hospital, Seoul, Republic of Korea.
Junhak AhnCenter for RNA Research, Institute for Basic Science, Seoul, Republic of Korea.
Daehyun BaekCenter for RNA Research, Institute for Basic Science, Seoul, Republic of Korea.
Tae-You KimDepartment of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Sung-Soo YoonCancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. ssysmc@snu.ac.kr.
Youngil KohCenter for Medical Innovation, Seoul National University Hospital, Seoul, Republic of Korea. go01@snu.ac.kr.
Seoul National University Hospital · KRSeoul National University · KRCancer Research Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a novel transcriptomic analysis workflow called LiEB (Life cycle of Epstein-Barr virus) to characterize distributions of oncogenic virus, Epstein-Barr virus (EBV) infection in human tumors. We analyzed 851 The Cancer Genome Atlas whole-transcriptome sequencing (WTS) data to investigate EBV infection by life cycle information using three-step LiEB workflow: 1) characterize virus infection generally; 2) align transcriptome sequences against a hybrid human-EBV genome, and 3) quantify EBV gene expression. Our results agreed with EBV infection status of public cell line data. Analysis in stomach adenocarcinoma identified EBV-positive cases involving PIK3CA mutations and/or CDKN2A silencing with biologically more determination, compared to previous reports. In this study, we found that a small number of colorectal adenocarcinoma cases involved with EBV lytic gene expression. Expression of EBV lytic genes was also observed in 3% of external colon cancer cohort upon WTS analysis. Gene set enrichment analysis showed elevated expression of genes related to E2F targeting and interferon-gamma responses in EBV-associated tumors. Finally, we suggest that interpretation of EBV life cycle is essential when analyzing its infection in tumors, and LiEB provides high capability of detecting EBV-positive tumors. Observation of EBV lytic gene expression in a subset of colon cancers warrants further research.

Indexed as

Genome, HumanCell Transformation, ViralEpstein-Barr Virus InfectionsGene Expression ProfilingHerpesvirus 4, HumanHigh-Throughput Nucleotide SequencingHumansLife Cycle StagesMolecular Diagnostic TechniquesMutationNeoplasmsReproducibility of ResultsTranscriptome

Identifiers

PMID30837539
PMCPMC6401378
OpenAlexW2918966954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.